Inclusion Criteria:
  -  Must agree to sign informed consent form, and to comply with protocol requirements, including study visits.
  -  Must have clear optic media in the study eye that is capable of producing high-quality fundus images.
Exclusion Criteria:
  -  Has active CNV due to causes other than AMD in the study eye.
  -  Has retinal vascular disease or retinal degeneration other than AMD in the study eye.
  -  Has had intraocular surgery, cataract surgery or LASIK surgery on the study eye within 90 days prior to the study.     
  -  Has had yttrium aluminum garnet (YAG) laser capsulotomy on the study eye within 30 days prior to the study.
  -  Has active inflammation, infection, or other severe ocular disease in either eye.
  -  Has aphakia in the study eye.
  -  Has uncontrolled glaucoma or a history of previous glaucoma filter surgery in either eye.
  -  Is a contact lens wearer and is unable to discontinue their use in both eyes for the duration of the study.
  -  Has a serious allergy to, or experienced a prior significant adverse reaction to fluorescein angiography (FA) or indocyanine green angiography (ICGA).
  -  Has participated in any other clinical trial and/or has taken any investigational drug or product within 90 days prior to the study.
Other protocol-defined inclusion/exclusion criteria could apply.
